Zhu's Pharmaceutical Group: Insulin-like Growth Factor Binding Protein-1 (IGFBP-1) Test Kit (Colloidal Gold Method) Obtained Medical Device Registration Certificate

Zhu's Pharmaceutical Group: Insulin-like Growth Factor Binding Protein-1 (IGFBP-1) Test Kit (Colloidal Gold Method) Obtained Medical Device Registration Certificate

On May 26th, Zhu's Pharmaceutical Group announced that Shandong Zhu's Pharmaceutical Group Co., Ltd. has received the "Medical Device Registration Certificate of the People's Republic of China" issued by the Shandong Provincial Drug Administration. The product is an insulin-like growth factor binding protein-1 (IGFBP-1) detection kit (colloidal gold method), expected to be used for in vitro qualitative detection of insulin-like growth factor binding protein (I) in vaginal secretions samples of pregnant women.

Shandong Zhushi Pharmaceutical Group Co., Ltd., founded in 2003, has more than 5000 registered employees. After years of development, it has developed into a diversified industrial cluster integrating medical devices, polymers, cosmetics, health food, daily necessities and biological reagent production, enterprise management consulting and training, real estate economy, pharmaceutical transportation, pharmaceutical printing, etc.

Adhering to the concept of life, health and happiness, the Group provides you with full chain health services.

HOT

NEW